It is a pharma public limited company based in Mylapore, Chennai.600 004, Tamil Nadu, India, established in 1994.
1994 | Mylapore, Chennai.600 004, Tamil Nadu, India | ActiveNovel Drugs Limited, a active public limited company, was established on 03 June 1994 in Mylapore, Chennai.600 004, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231TN1994PLC027710. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.20 M.
It upholds a active non-compliant status. Its leadership includes Karunakaran Sebastin (Director), Gnanatilakan Sebastian (Director), Mary Vasundra Justine (Director). Past directors included Soorya Narayanan Venkatrama. It holds ₹8.77 Cr open charges and no settled loans. It is based at No.33, Nainar Roadmylapore, Chennai.600 004, Mylapore, Chennai.600 004, Tamil Nadu.
U24231TN1994PLC027710
027710
03 June 1994
₹2.00 Cr
₹1.20 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Novel Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karunakaran Sebastin | Director | 03 Jun 1994 | Current |
| Gnanatilakan Sebastian | Director | 30 Jul 1996 | Current |
| Mary Vasundra Justine | Director | 14 Aug 2008 | Current |
| Chandra Gnanatilakan | Director | 14 Aug 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 18 Aug 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Novel Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Novel Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹87,675,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2005 | State Bank Of India | ₹3.48 Cr | Open |
| 27 Jan 2005 | State Bank Of India | ₹2.41 Cr | Open |
| 18 Dec 2003 | State Bank Of India | ₹1.96 Cr | Open |
| 31 Mar 2000 | The Lakshmi Vilas Bank Ltd. | ₹7.70 M | Open |
| 23 Sep 1996 | State Bank Of India | ₹1.48 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novel Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novel Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mary Vasundra Justine was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 3 months . was recorded as a recent event.
Chandra Gnanatilakan was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 3 months . was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 3.48 Cr with Charge ID 90321165 was registered on 16 Mar 2005. was completed.
The activity A charge with State Bank Of India amounted to Rs. 2.41 Cr with Charge ID 90322299 was registered on 27 Jan 2005. was completed.
A charge with State Bank Of India amounted to Rs. 1.96 Cr with Charge ID 90322291 was registered on 18 Dec 2003. was recorded as a recent event.
A charge with The Lakshmi Vilas Bank Ltd. amounted to Rs. 0.77 Cr with Charge ID 90321014 was registered on 31 Mar 2000. was recorded as a recent event.
The CIN of Novel Drugs Limited is U24231TN1994PLC027710.
Novel Drugs Limited is headquartered at No.33, Nainar Roadmylapore, Chennai.600 004, Mylapore, Chennai.600 004, Tamil Nadu.
Novel Drugs Limited was incorporated on 03 June 1994.
The current directors of Novel Drugs Limited are
The primary industry of Novel Drugs Limited is Pharma.
Novel Drugs Limited is unlisted.
The authorized capital of Novel Drugs Limited is ₹2.00 Cr, and the paid-up capital is ₹1.20 M.
The compliance status of Novel Drugs Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX